(Q38875931)

7 September 2017

title

Co-trimoxazole, cART, and non-AIDS infectious diseases (English)

1 reference

sulfamethoxazole/trimethoprim

7 September 2017

main subject

1 reference

1

Xavier Anglaret

1 reference

7 September 2017

Serge Eholie

2

1 reference

7 September 2017

language of work or name

English

0 references

publication date

27 March 2010

1 reference

7 September 2017

1 reference

7 September 2017

volume

375

1 reference

7 September 2017

issue

9722

1 reference

7 September 2017

page(s)

1231-1233

1 reference

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960200-0

7 January 2021

10.1016/S0140-6736(10)60200-0

Identifiers

DOI

1 reference

7 September 2017

1 reference